MedTech News
.................... by Andrew Celentano
AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery
The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.
First AI-designed ‘universal vaccine’ tested in humans: UK researchers
The new vaccine aims to produce an immune response that will protect against many pathogens—including some circulating among wild animals that might jump into humans in the future.
Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows
A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer Institute and professor of internal medicine at the University of Utah (the U), has found that a combination prostate cancer treatment could prevent the disease from progressing into a harder-to-treat form of cancer in select patients.
New hantavirus sequencing tool maps whole genomes from hard-to-test samples
A new method for whole-genome sequencing of hantaviruses improves on today’s strategies for identifying outbreaks.
GE HealthCare Receives FDA 510(k) Clearance for MIM Contour ProtégéAI+ 2.0 to Advance AI-Enabled Radiation Therapy Planning
GE HealthCare has received FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, an AI-enabled auto-contouring software designed to assist radiation oncology care teams with treatment planning.
Zepto Life Technology’s mould infection panel obtains FDA breakthrough designation
Zepto Life’s FungiFlex mould panel is designed to identify 14 clinically important mould species based on cell free fungal DNA detected in plasma.
Tandem wins CE mark for automated insulin delivery in type 2 diabetes, pregnancy
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received expanded CE mark for its automated insulin delivery (AID) systems.
Blood test spots 14 proteins that predict lung cancer risk up to five years early
Published today in Cell, the team applied machine learning to blood plasma protein data from more than 48,000 UK Biobank participants, using matched cancer registry records to identify those who later developed lung cancer.